-nicline
Drugs that partly or fully activate nicotinic receptors, like varenicline.
- Drugs ending in -nicline: 12
- Approved somewhere: 1
- With a US drug page: 1
- Stem
- -nicline
- Class
- Drugs that partly or fully activate nicotinic receptors, like varenicline
- Most common targets
- CHRNA4, CHRNB2 (8), CHRNA7 (3), Serotonin 3 (5-HT3) receptor (1), Nicotinic acetylcholine receptor alpha4/beta2/alpha5 (1), CHRNA6, CHRNB2 (1), CHRNA3, CHRNB4 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -nicline, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Varenicline | Approved | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 agonist |
| Cytisinicline | Phase 3 | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 partial agonist |
| Dianicline | Phase 3 | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 partial agonist |
| Encenicline | Phase 3 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist |
| Bradanicline | Phase 2 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit agonist |
| Facinicline | Phase 2 | CHRNA7, Serotonin 3 (5-HT3) receptor | Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist |
| Ispronicline | Phase 2 | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 partial agonist |
| Pozanicline | Phase 2 | Nicotinic acetylcholine receptor alpha4/beta2/alpha5, CHRNA6, CHRNB2 | Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist |
| Simpinicline | Phase 2 | CHRNA4, CHRNB2, CHRNA3, CHRNB4 | Neuronal acetylcholine receptor; alpha4/beta2 agonist |
| Sofinicline | Phase 2 | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 agonist |
| Altinicline | — | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 agonist |
| Tebanicline | — | CHRNA4, CHRNB2 | Neuronal acetylcholine receptor; alpha4/beta2 agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO